Klowverine
KLOW-verine · Klowverine blend · double KLOW
What is in the vial
| Compound | Per vial | Share |
|---|---|---|
| GHK-CuLargest component by mass and the source of the blue colour. Unchanged from KLOW. | 50 mg | 45% |
| BPC-157Doubled from KLOW. Associated with angiogenesis in animal models. | 20 mg | 18% |
| TB-500Doubled from KLOW. Associated with cell migration through actin binding. | 20 mg | 18% |
| KPVDoubled from KLOW. Anti-inflammatory in cell and animal work. | 20 mg | 18% |
The ratio is fixed in the vial. Choosing a dose of one component chooses the dose of all the others — you cannot move one without moving them all.
What the contents cost separately
The same masses this vial holds, bought as individual vials, at the cheapest confirmed listing and at the median across vendors. We do not price blend vials themselves — hold this against whatever you are being quoted.
$212–$262
for 110 mg across 4 compounds
| Compound | In this vial | Separately |
|---|---|---|
| GHK-Cu | 50 mg | $22–$27 |
| BPC-157 | 20 mg | $60–$70 |
| TB-500 | 20 mg | $70–$90 |
| KPV | 20 mg | $60–$75 |
Buying separately costs more injections and more vials, and buys back the ability to change one dose without changing the others. Prices are read from vendor sites and normalised per milligram; we take no vendor placement. Every listing.
Klowverine is KLOW with BPC-157, TB-500 and KPV each doubled from 10 mg to 20 mg, leaving GHK-Cu at 50 mg. That makes a 110 mg vial at roughly 2.5:1:1:1, against KLOW's 80 mg at 5:1:1:1.
The name is a portmanteau of KLOW and Wolverine, and the formulation follows it: the repair peptides Wolverine is built on, at twice the KLOW share, with KLOW's copper and KPV still there.
It is the least documented blend on this page. Searching the name returns KLOW product listings rather than a specification, and the ratio here is reported community practice rather than a published or manufacturer figure. Treat the composition of any vial you are handed as unconfirmed until the seller states it.
How it works
Four separate mechanisms arriving together, none studied in combination, and no study of this ratio specifically.
GHK-Cu delivers copper for collagen and elastin synthesis.
BPC-157 is associated with angiogenesis in animal models.
TB-500 binds actin and is associated with cell migration.
KPV is a tripeptide fragment of alpha-MSH with anti-inflammatory activity in cell and animal work.
Regulatory status — United States
Not approved anywhere as a mixture or as any of its parts. Sold as a research chemical, and less consistently documented than KLOW — the ratio is reported rather than specified.
Last reviewed 25 Aug 2026. Regulatory positions in this category change frequently; we date this line so you can see how current it is.
What it is studied for
Each entry states the evidence behind it. We do not rank indications by effectiveness — for most compounds here, that would be a claim nobody can support.
Tissue repair with an anti-inflammatory component
Published reviewWhat the combination is sold for.
EvidenceNo study of the mixture or of this ratio exists. Every component is separately supported by animal or cell-culture work only.
Identity and clearance
Molecule
- Class
- Pre-mixed blend of four peptides, roughly 2.5:1:1:1 by mass
A 110 mg vial is 50 mg GHK-Cu with 20 mg each of BPC-157, TB-500 and KPV. Reported ratio; no manufacturer specification is published.
Dose protocols reported in sources
Displayed for reference only. Every row says where it came from, and a trial protocol and a community convention are not the same kind of information. None of this is fed into the calculator, and none of it is a recommendation.
| Goal | Dose | Frequency | Route | Units, 110 mg vial | Source | Start this protocol |
|---|---|---|---|---|---|---|
| Commonly described community protocol | 2.2 mg – 4.4 mg | Daily, in courses of 4 to 8 weeks | SubcutaneousTotal blend. At 2.5:1:1:1, 2,200 mcg of blend delivers 400 mcg each of BPC-157, TB-500 and KPV alongside 1,000 mcg of GHK-Cu. | 10–20 u | Community practice | Start this |
Start this copies a row into a protocol of your own, which you can then edit. Where a source gave a dose range or an ambiguous frequency, those fields arrive empty — we will not pick a number on your behalf.
CheckRows marked community practice describe what people commonly do, drawn from public discussion. They are not derived from any trial and are not evidence that a dose is safe or effective.
Calculator
Work out what to draw
Pre-filled with a 110 mg vial as a worked example. These are not recommended values — change them to match the vial in front of you.
Draw to 10 units on a 1 mL U-100 syringe. That is 0.1 mL, containing 2.2 mg of Klowverine.
10 units sits exactly on a printed line.
Bioalmanac performs arithmetic on values you enter. It does not recommend doses, schedules or compounds, and nothing here is medical advice. Confirm every calculation against your vial and syringe before drawing, and speak with a licensed healthcare provider.
Open this calculation in the full calculator
Units, concentration, bacteriostatic water — the glossary defines the vocabulary, and a unit is not a fixed volume.
Safety
Reported effects
- Everything from four compounds at oncePublished review
Unknown
No human study of the mixture. Each component's own adverse-effect profile applies, and they cannot be separated if something goes wrong.
- Injection site reactionsCommunity practice
Commonly reported
When to stop
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
- An injection site that becomes hot, spreading or produces pus.
- Any new or changing lump. Several components are associated with proliferation in animal models.
Interactions and situations that need care
- Active or previous cancerAvoid
Components associated with angiogenesis and proliferation in animal models, none studied in anyone with a malignancy.
- Wilson's disease or any copper metabolism disorderAvoid
GHK-Cu delivers copper deliberately and is the largest component.
- Pregnancy and breastfeedingAvoid
No safety data for any component, let alone the mixture.
- Wanting to control the dose of one componentUse caution
Four compounds at a fixed ratio means four doses chosen at once. Running them separately is the only way to dose them separately.
- Competing in a tested sportAvoid
Components are WADA S2, prohibited at all times.
SportProhibited by the World Anti-Doping Agency under S2: Peptide Hormones, Growth Factors, Related Substances, at all times, in and out of competition.
What to expect
HonestlyThere is no human efficacy data for this compound, so there is no evidence-based timeline to give. Any site publishing a week-by-week schedule of expected effects has invented it.
- The least documented blend here. The ratio is reported community practice, not a published specification.
- No study of the mixture, and none of this ratio against KLOW's.
- Four fixed doses chosen at once. GHK-Cu is still the largest share, at two and a half times any other component.
- Doubling the repair peptides also doubles what you cannot attribute if you react to it.
Storage and handling
- Freeze-dried powder
- Refrigerated at 2–8 °C, protected from light.
- After mixing
- Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
- Long-term, frozen
- Unopened powder is stable at −20 °C or colder.
With other peptides
- KLOWcaution
This is KLOW with three of its four components doubled. Running both means taking all four twice, at an unclear total.
- GLOWcaution
GLOW is three of these four components. Running both means taking GHK-Cu, BPC-157 and TB-500 twice.
- Wolverinecaution
Wolverine is BPC-157 and TB-500, both already here at 20 mg. Running both doubles them again.
- Deadpoolcaution
Deadpool is three of this blend's four components. Running both means taking BPC-157, TB-500 and KPV twice.
Checking your vial
Research chemicals carry no manufacturing standard, so what the vial looks like is often the only quality signal available before you use it. More on assessing quality and COAs.
Blue solution after reconstitution
The copper complex, as in GLOW and KLOW.
Cloudiness or visible particles
Discard it.
No stated ratio
This blend is poorly documented and the name is close to KLOW's. Without a stated split you cannot tell which of the two you have, and they differ by twice the repair peptides.
Questions
- How is Klowverine different from KLOW?
- The GHK-Cu is the same at 50 mg. BPC-157, TB-500 and KPV are each 20 mg rather than 10, making a 110 mg vial instead of 80. Per milligram of blend you therefore get less GHK-Cu and more of everything else.
- Where does this composition come from?
- Community practice. No manufacturer specification for a blend under this name is published, and searching the name mostly returns KLOW listings. We record the reported ratio and say so rather than presenting it as established.
- Can I use a KLOW protocol for it?
- Not without redoing the arithmetic. The same volume of a Klowverine vial delivers a different amount of every component, so a dose in units or millilitres carried over from KLOW is wrong in four ways at once.
References
Component evidence for common peptide blends: an assessment of what is known separately
Preclinical peptide literature, 2024 · Assessment of the separate component literatures
Cell culture and rodent models
Every component of the common blends is supported by animal or cell-culture work only. No study has examined any of these combinations as a mixture, so combination evidence is weaker than the single-compound evidence. That is itself preclinical.
Community and vendor practice, unverified
Vendor listings and community protocols, 2026 · Anecdote
Self-selected, unverified
Ratios and doses as vendors sell and users describe them. Ratios vary between sellers, so a blend bought from two vendors is not necessarily the same product.
Related compounds
KLOW
GLOW with KPV added: four compounds in one vial at 5:1:1:1. The newest and least studied of the common blends.
GLOW
A pre-mixed vial of GHK-Cu, BPC-157 and TB-500 at 5:1:1. One draw delivers all three, in proportions most people underestimate.
Wolverine
BPC-157 and TB-500 in one vial at 1:1. The oldest and simplest of the named blends, and the only one without a settled vial size.
Deadpool
Wolverine with KPV added and the ratio tilted toward TB-500: 10 mg TB-500 with 5 mg each of BPC-157 and KPV. Documented at a single vendor.
Next
What to do with Klowverine
- Keep a record of itTurn a dose and a schedule into a protocol, then log what you actually take. Klowverine is filled in for you.
- See what it costsPer-milligram prices read from vendor sites and confirmed by a person, so vial sizes compare.
- Check a combinationWhat our profiles record about Klowverine alongside each other compound — including the pairs where nothing is recorded.
Keep this page honest
If something here is wrong, out of date, or missing a source, tell us and we will fix it and say that we did.
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice. No clinician reviews these pages.
Page last updated 25 Aug 2026